Sommario

• • ·Editorial board

    Pagina :i

    

• Pharmacovigilance/Pharmacovigilance

  • ·L’activité de recueil des centres régionaux de pharmacovigilance est-elle influée par des déterminants régionaux démographiques ou sanitaires ?

    Is the collecting activity of regional pharmacovigilance centers influenced by regional demographic or health determinants?

    Pagina :333-341

    Laurent Lam, Christelle Desitter, Patrick Maison

    Riassunto Riassunto Mappa Mappa
  • ·Adverse reactions related to brentuximab vedotin use: A real-life retrospective study

    Pagina :343-346

    Béatrice Clarivet, Laure Vincent, Laurence Vergely, Virginie Bres, Kathleen Foglia, Guillaume Cartron, Dominique Hillaire-Buys, Jean-Luc Faillie

    Riassunto Riassunto Mappa Mappa  
  • ·Vascularites médicamenteuses : à propos d’une série de 13 cas

    Drug-induced vasculitis

    Pagina :347-354

    Neila Fathallah, Bouraoui Ouni, Sana Mokni, Khadija Baccouche, Amira Atig, Najat Ghariani, Awatef Azzabi, Mohamed Denguezli, Raoudha Slim, Chaker Ben Salem

    Riassunto Riassunto Mappa Mappa
  • ·Acceptabilité et efficacité des immunothérapies dans le traitement du mélanome

    Acceptability and effectiveness of immunotherapy in patients with melanoma

    Pagina :355-367

    Marie-Blanche Valnet-Rabier, Charles Marcucci, Samuel Limat, Siamak Davani, François Aubin, Virginie Nerich

    Riassunto Riassunto Mappa Mappa  
  • ·Association illogique nalméfène et opioïdes : analyse dans la base française de pharmacovigilance

    Illogical association nalmefene and opioids: Analysis in the French pharmacovigilance database

    Pagina :369-374

    Sylvie Favrelière, Claire Lafay-Chebassier, Bernard Fauconneau, Alexandre Quillet, Mélissa Yéléhé-Okouma, François Montastruc, Marie-Christine Pérault-Pochat

    Riassunto Riassunto Mappa Mappa  

• Addictovigilance/Addictovigilance

  • ·Du médicament psychoactif à l’addictovigilance dans le Code de la santé publique en France (1990–2017)

    From psychoactive medicines to addictovigilance in French Public Health Code (1990–2017)

    Pagina :375-382

    Marie Baumevieille, Joëlle Perri-Plandé, Ghada Miremont-Salamé, Amélie Daveluy, Françoise Haramburu

    Riassunto Riassunto Mappa Mappa
  • ·Améliorer la balance bénéfices/risques de la méthadone en respectant ses spécificités pharmacologiques

    Improve the benefit/risk balance of methadone by respecting its pharmacological specificities

    Pagina :383-388

    Elisabeth Frauger, Nathalie Fouilhé Sam-Laï, Michel Mallaret, Joëlle Micallef, le French Addictovigilance Network (FAN)

    Riassunto Riassunto Mappa Mappa  
  • ·Identification de cas d’abus/dépendance par le réseau français d’addictovigilance : une étude pilote du CEIP-A et du Centre psychothérapique de Nancy

    Identification of abuse/dependence cases by the French addictovigilance network (FAN): A pilot study of the addictovigilance center and the psychotherapeutic center of Nancy (France)

    Pagina :389-397

    Pauline Barberot, Valérie Gibaja, Célia Benkhedda, Daniela Dobre, Juliana Tournebize, Jean-Pierre Kahn

    Riassunto Riassunto Mappa Mappa  

• Pharmacogénétique/Pharmacogenetics

  • ·Transforming growth factor-beta 1 polymorphisms and anti-tuberculosis drug-induced liver injury. Polymorphisms in TGF?1 and its relationship with anti-tuberculosis drug-induced liver injury

    Pagina :399-406

    Shouquan Wu, Yu Wang, Miaomiao Zhang, Minggui Wang, Jian-Qing He

    Riassunto Riassunto Mappa Mappa  

• Pharmacologie clinique/Clinical pharmacology

  • ·Impact des benzodiazépines sur les fonctions cognitives et le risque de démence. Revue des arguments de causalité issus des études observationnelles

    Benzodiazepines, cognitive decline and dementia: A review of causality criteria from published observational studies

    Pagina :407-419

    Maryse Lapeyre-Mestre

    Riassunto Riassunto Mappa Mappa

• Pharmacoepidemiologie/Pharmacoepidemiology

  • ·Association between venous thromboembolism events and fibrates: A comparative study

    Pagina :421-430

    Charles Dolladille, Xavier Humbert, Murielle Faucon, Claire Tournilhac, Marion Sassier, Sophie Fedrizzi, Paul Milliez, Véronique Lelong-Boulouard, Antoine Coquerel, Paolo Emilio Puddu, Jean-Jacques Parienti, Joachim Alexandre

    Riassunto Riassunto Mappa Mappa  

• Pharmacologie sociale/Social pharmacology

  • ·The French Levothyrox^® crisis: We did the best we could but…

    Pagina :431-435

    Stéphane Mouly, Matthieu Roustit, Haleh Bagheri, Marie-Christine Perault-Pochat, Mathieu Molimard, Régis Bordet

    Mappa Mappa  

• Lettres à la rédaction/Letters to editor

  • ·Decompensation of adrenal insufficiency associated with birch juice use as stated by the manufacturer information leaflet: A case report

    Pagina :437-440

    Cécile Fokoun, Vanessa Labeye, Elodie Puzenat, Marina Atzenhoffer, Alain Sigal, Bruno Charpiat

    Mappa Mappa
  • ·Clozapine-induced myocarditis: A rare adverse drug reaction not to ignore

    Pagina :441-444

    Rim Masmoudi, Imen Baati, Kamilia Ksouda, Imen Abida, Rim Sellami, Hanene Affes, Dorsaf Trigui, Jawaher Masmoudi, Ines Feki

    Mappa Mappa
  • ·Tintin in the Land of Drugs: A pharmacological, pharmacovigilance approach

    Pagina :445-447

    Jean-Louis Montastruc, François Montastruc, Justine Benevent, Isabelle Lacroix, Geneviève Durrieu, Jean-Michel Du Plantier, Haleh Bagheri, Agnès Sommet, Christine Damase-Michel

    Mappa Mappa
  • ·Interferon ?-induced acute pancreatitis: About two cases with literature review

    Pagina :449-450

    Imen Aouinti, Imen Hamza, Ons Charfi, Ghozlane Lakhoua, Sihem El Aidli, Riadh Daghfous, Ahmed Zaiem, Sarrah Kastalli

    Mappa Mappa